Related Experiment Video

Updated: Jul 8, 2025

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

5.4K

The development of cancers research based on mitochondrial heat shock protein 90

Yuchu Xiang1, Xudong Liu2, Qi Sun3

  • 1West China Hospital of Sichuan University, Sichuan University, Chengdu, China.

Frontiers in Oncology
|December 15, 2023
PubMed

Insights

Mitochondrial heat shock protein 90 (mtHsp90) is highly expressed in tumors and crucial for cancer cell development. Inhibiting mtHsp90 with compounds like gamitrinib shows promise for cancer therapy.

Area of Science:

  • Mitochondrial biology
  • Cancer cell signaling
  • Drug discovery

Background:

  • Mitochondrial heat shock protein 90 (mtHsp90) plays a key role in cancer by modulating cellular metabolism and signaling pathways.
  • mtHsp90, including TRAP1, is highly expressed in tumors and affects client protein stability.
  • Inhibition of mtHsp90 leads to client protein degradation, impacting tumor-related pathways.

Purpose of the Study:

  • To provide a comprehensive overview of mitochondrial heat shock protein 90 (mtHsp90).
  • To review the structure and function of mtHsp90.
  • To highlight the development of mtHsp90 inhibitors for cancer therapy.

Main Methods:

  • Literature review of preclinical and clinical studies on mtHsp90 inhibitors.
  • Analysis of mtHsp90's role in cancer cell metabolism and signaling.
  • Evaluation of gamitrinib and other mtHsp90 inhibitors in cancer treatment.

Main Results:

  • mtHsp90 inhibition destabilizes client proteins, interfering with cancer cell development.
  • Gamitrinib, a specific mtHsp90 inhibitor, shows safety and efficacy in preclinical studies.
  • Ongoing clinical trials are evaluating mtHsp90 inhibitors for cancer therapy.

Conclusions:

  • mtHsp90 is a promising therapeutic target in oncology.
  • mtHsp90 inhibitors, such as gamitrinib, represent a novel strategy for cancer treatment.
  • Further research and clinical trials are essential to fully realize the potential of mtHsp90-targeted therapies.
Keywords:
TRAP1gamitrinibmitochondriamolecular chaperonemtHsp90

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K
Author Spotlight: A Three-Dimensional Technique for the Visualization of Mitochondrial Ultrastructural Changes in Pancreatic Cancer Cells08:46

Author Spotlight: A Three-Dimensional Technique for the Visualization of Mitochondrial Ultrastructural Changes in Pancreatic Cancer Cells

Published on: June 23, 2023

1.7K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.8K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
10.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K